XIRISIV

Swiss trademark · 462730 · Word mark · Deleted

Register entry

Registration number
462730
Application number
00116/1999
Status
Deleted
Type
Word mark
Filed
Jan 7, 1999
Registered
Jul 7, 1999
Published
Jul 30, 1999
Deleted
Aug 10, 2009
Reason
Not renewed
Priority
24.07.1998 GB
Remarks
Teilpriorität, detaillierte Angaben im Aktenheft.
Source
Swissreg

Goods and services

Pharmaceuticals

Impfstoffe, insbesondere für die Prävention und/oder Behandlung von Atemwegserkrankungen beim Menschen.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 10, 2009

    Deleted, not renewed

    Published in Swissreg on 10.08.2009

  2. May 5, 2008

    Agent’s address changed

    Representative
    A. Braun, Braun, Héritier,, Eschmann AG, Patentanwälte, Holbeinstrasse 36-38, 4051 Basel → BOHEST AG, Postfach 160, 4003 Basel

    Published in the SOGC no. 85 of 05.05.2008

  3. May 12, 2003

    Holder’s address changed

    Owner
    SmithKline Beecham Biologicals, Manufacturing S.A., Rue de l'Institut 89, 1330 Rixensart, Belgium → GlaxoSmithKline Biologicals Manufacturing S.A., Rue de l'Institut 89, 1330 Rixensart, Belgium

    Published in the SOGC no. 89 of 12.05.2003

  4. Jul 30, 1999

    Registered

    Published in the SOGC no. 146 of 30.07.1999

Parties

Holder

GlaxoSmithKline Biologicals Manufacturing S.A.

Rue de l'Institut 89, 1330 Rixensart, BE

Agent

BOHEST AG

Postfach 160, 4003 Basel

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.